Zobrazeno 1 - 6
of 6
pro vyhledávání: '"R. Zel'chan"'
Publikováno v:
Medical Radiology and radiation safety. 66:78-82
This publication demonstrates the possibility of dynamic observation of a patient with a diagnosis of a malignant brain tumor at the stages of combined treatment using SPECT with a new radiopharmaceutical drug 99mTc-1-thio-D-glucose. Also in the desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::330846cc0f14e82b62ad47382eb4592e
https://doi.org/10.12737/1024-6177-2021-66-2-78-82
https://doi.org/10.12737/1024-6177-2021-66-2-78-82
Publikováno v:
Journal of oncology: diagnostic radiology and radiotherapy. 3:26-38
The presented material summarizes the experience of Cancer Research Institute and Tomsk Polytechnical University team in the development of original radiopharmaceuticals (RP) for nuclear medicine. The first such unique for world nuclear medicine RP w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72e60511e1bf80750f06b074b657a3ec
https://doi.org/10.37174/2587-7593-2020-3-4-26-38
https://doi.org/10.37174/2587-7593-2020-3-4-26-38
Autor:
Anzhelika Vorobyeva, A. Medvedeva, A. Shulga, V. Chernov, G. M. Proshkina, M. S. Lar’kina, R. Zel'chan, Vladimir M. Tolmachev, O. Bragina, Anna Orlova, Sergey M. Deyev
Publikováno v:
Medical Radiology and radiation safety. 65:37-41
Purpose: Evaluation of a radiopharmaceutical based on 99mTc-labeled targeted molecules DARPin9_29 for radionuclide diagnostics of malignancies with Her2/neu overexpression. Material and methods: The DARPin9_29 sequence was amplified from the plasmid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::933542dc001a4c999559f41ac76cf62c
https://doi.org/10.12737/1024-6177-2020-65-1-37-41
https://doi.org/10.12737/1024-6177-2020-65-1-37-41
Publikováno v:
Medical Radiology and radiation safety. 64:35-41
Purpose: To study the features of the distribution and removal of a new radiopharmaceutical (RPH) on the basis of a labeled 99mTc glucose derivative for radionuclide diagnostics of oncological diseases in the body of experimental animals. Material an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74c25b46d9fa24d5f1b7d8dac4fe5c2b
https://doi.org/10.12737/1024-6177-2019-64-5-35-41
https://doi.org/10.12737/1024-6177-2019-64-5-35-41
Autor:
V E Goldberg, T. Kravchuk, A. Medvedeva, A. Danilova, Yu. V. Belevich, V. Chernov, E. Dudnikova, R. Zel'chan, I. Sinilkin, O. Bragina, E. Koroleva
Publikováno v:
Medical Radiology and radiation safety. :58-63
Despite the high efficiency of the use of 18F-FDG PET in the diagnosis, staging, monitoring and prognosis of treatment of lymphomas, the use of this method in our country is limited due to the high cost and the insufficient number of PET-centers. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4864e60279abc21f9ccf5f40924dacd9
https://doi.org/10.12737/article_5cf3dfefe60b13.90120976
https://doi.org/10.12737/article_5cf3dfefe60b13.90120976
Autor:
T. Kravchuk, O. Bragina, R. Zel'chan, V E Goldberg, I. Sinilkin, V. Chernov, N. O. Popova, A. Medvedeva, A. Danilova, E. Dudnikova, A. V. Goldberg
Publikováno v:
Medical Radiology and radiation safety. 63:41-50
Currently, 18F FDG-PET and 18F FDG-PET/CT are widely used for diagnosis and monitoring of lymphomas. The majority of aggressive lymphomas are characterized by high glycolytic activity, which enables the visualization by using 18F FDG-PET/CT. The use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::689bafd6ca55496a6325b2a7d5c00164
https://doi.org/10.12737/article_5c0b8d72a8bb98.40545646
https://doi.org/10.12737/article_5c0b8d72a8bb98.40545646